Tail winds for RMD?

RMD CEO Mick Farrell says he's sees "....Potentially some tail winds in tariffs." Click here to see video he talks tariffs at approximately 10min mark, but the whole video is worth checking out for RMD investors.

Meanwhile.....

The New Zealand-based, ASX-listed Fisher & Paykel Healthcare is straight out of the blocks this morning announcing it will be hurt by the new regime of US tariffs.

In a statement to the ASX this morning, the company said while it didn't expect any impact in the 2025 financial year, 2026 was a different matter.

Fisher & Paykel Healthcare currently manufactures around 45% of its volume in Mexico and 55% in New Zealand.

Late on Friday (Saturday morning AEDT), US President Donald Trump announced he would be hitting Mexico with a 25% tariff, along with a 25% tariff on Canada and 10% on China on Tuesday,

"For the 2026 financial year, the company's cost would likely increase to the introduction of the new tariffs, acknowledging that the economic environment, global response to US tariffs and foreign currency movements may be fluid over this period," Fischer & Paykel's statement said.

It said it would update the market on the impact on its gross margins when it releases full year results in May.